Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Betterlife Pharma Inc
(OP:
BETRF
)
0.0421
+0.0111 (+35.81%)
Streaming Delayed Price
Updated: 1:28 PM EST, Dec 29, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Betterlife Pharma Inc
< Previous
1
2
Next >
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
May 28, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Provides Comments on CEO’s Share Position Ownership and Recent BCSC Press Release
May 22, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Pharma Provides Scientific Update of Mechanism of Action of BETR-001 in Treatment of Psychiatric Disorders
May 14, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Debt Settlements
May 06, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Microcap Stocks to Watch: STSS, AGMH, FMTO, SUNE, Signal Strength Amid Market Volatility – More Picks Inside
April 10, 2025
Via
AB Newswire
Topics
Artificial Intelligence
BetterLife Pharma Appoints Corporate Advisor
April 03, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Pharma Appoints New Director
March 31, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Debt Conversions
March 10, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
USPTO Grants BetterLife’s BETR-001 Composition of Matter Patent
January 14, 2025
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Favorable Outcome in New York Legal Claims
December 09, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Favourable Cardiac Safety Data for BETR-001
November 25, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Favourable Genotoxicity Data for Oral BETR-001
October 23, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Fully Subscribed Private Placement Financing
August 29, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Highlights Advantages of Non-hallucinogenic LSD Derivative BETR-001 and Publication of its Methods to Treat Mood Disorders Patent
August 27, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
July 02, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife To Present BETR-001 Preclinical Data at the 2024 Conference of the Federation of European Neuroscience Societies (FENS) in Vienna, Austria
June 26, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
June 14, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Obtains Excellent Animal Cardiopulmonary Safety Data for Oral BETR-001
May 14, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Intent to Complete Private Placement of Units
May 03, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Advances BETR-001 IND-enabling Studies
May 01, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More
↗
April 17, 2024
Via
Benzinga
BetterLife To Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
April 11, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of $1.168 Million Convertible Debentures to Further Advance IND-enabling Studies of its Non-hallucinogenic LSD-based Drug Candidate BETR-001
April 03, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
↗
March 16, 2024
Via
Benzinga
BetterLife Announces Closing of Convertible Debentures For Further Development of BETR-001
January 02, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife’s 2-Bromo-LSD for Treatment of Depression Highlighted by Carleton University
March 04, 2024
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Closing of a Private Placement
December 18, 2023
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Announces Extension of Warrants
November 30, 2023
From
BetterLife Pharma Inc.
Via
GlobeNewswire
BetterLife Pharma to Host Investors Update Call on September 18, 2023
September 14, 2023
From
BetterLife Pharma Inc.
Via
GlobeNewswire
US Patent and Trademark Office Publishes BetterLife’s Comprehensive Patent for BETR-001 and Other LSD Derivatives
November 15, 2023
From
BetterLife Pharma Inc.
Via
GlobeNewswire
< Previous
1
2
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
